These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18248671)

  • 41. The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
    Li R; Zhang K; Penedo TL; Kragel CP; Grizzle WE; Hameed O; Siegal GP; Wei S
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):42-50. PubMed ID: 26200837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic analyses of key genes and pathways in the development of invasive breast cancer.
    Hou L; Chen M; Wang M; Cui X; Gao Y; Xing T; Li J; Deng S; Hu J; Yang H; Jiang J
    Gene; 2016 Nov; 593(1):1-12. PubMed ID: 27506314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
    Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.
    Nguyen DM; Sam K; Tsimelzon A; Li X; Wong H; Mohsin S; Clark GM; Hilsenbeck SG; Elledge RM; Allred DC; O'Connell P; Chang JC
    Clin Cancer Res; 2006 Sep; 12(17):5047-54. PubMed ID: 16951220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
    Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
    Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.
    Van Laere S; Beissbarth T; Van der Auwera I; Van den Eynden G; Trinh XB; Elst H; Van Hummelen P; van Dam P; Van Marck E; Vermeulen P; Dirix L
    Clin Cancer Res; 2008 Nov; 14(22):7452-60. PubMed ID: 19010862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells.
    Shibata A; Nagaya T; Imai T; Funahashi H; Nakao A; Seo H
    Breast Cancer Res Treat; 2002 Jun; 73(3):237-43. PubMed ID: 12160329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
    Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
    Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
    Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
    J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
    J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
    Wolf B; Goebel G; Hackl H; Fiegl H
    BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis.
    Liu B; Sun L; Liu Q; Gong C; Yao Y; Lv X; Lin L; Yao H; Su F; Li D; Zeng M; Song E
    Cancer Cell; 2015 Mar; 27(3):370-81. PubMed ID: 25759022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
    Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules.
    Liu-Mares W; Sun Z; Bamlet WR; Atkinson EJ; Fridley BL; Slager SL; de Andrade M; Goode EL
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S126. PubMed ID: 18466468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.
    Zare A; Petrova A; Agoumi M; Amstrong H; Bigras G; Tonkin K; Wine E; Baksh S
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29874851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
    Tang X; Wang X; Zhao YY; Curtis JM; Brindley DN
    Mol Cancer; 2017 Feb; 16(1):36. PubMed ID: 28178994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
    Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
    Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.
    Mohamed HT; El-Ghonaimy EA; El-Shinawi M; Hosney M; Götte M; Woodward WA; El-Mamlouk T; Mohamed MM
    Toxicol Appl Pharmacol; 2020 Aug; 401():115092. PubMed ID: 32512068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
    Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
    Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.